1. Home
  2. ICD-10-PCS Index
  3. Administration
  4. Physiological Systems and Anatomical Regions
  5. Introduction
  6. 3E0134Z
Version 2024
Billable Code

2024 ICD-10-CM Procedure Code 3E0134Z

Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach

ICD-10-PCS Code:
3E0134Z
ICD-10-PCS Code for:
Introduction of Serum/Tox/Vaccine into Subcu, Perc Approach
Is Billable?
Yes - Valid for Submission
Code Navigator:

3E0134Z is a billable procedure code used to specify the performance of introduction of serum, toxoid and vaccine into subcutaneous tissue, percutaneous approach. The code is valid for the year 2024 for the submission of HIPAA-covered transactions.

3E0134Z PCS Table

In an PCS table each code is represented by up seven alphanumeric characters, with each character in the table respresenting different aspects of the procedure. In the table provided below, each row represents an individual character and includes information about the character's position, designation, label, and procedure notes. For this PCS table the procedure code is in the administration section and is part of the physiological systems and anatomical regions body system, classified under introduction operation. The applicable bodysystem/region for this procedure code is subcutaneous tissue.

Position Designation Character Label Procedures Notes
1 Section 3 Administration
2 Body System E Physiological Systems and Anatomical Regions
3 Operation 0 Introduction

Involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
4 BodySystem/Region 1 Subcutaneous Tissue  
5 Approach 3 Percutaneous

Involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
6 Substance 4 Serum, Toxoid and Vaccine
7 Qualifier Z No Qualifier

Explanation:
The value Z is used for the seventh character to indicate that a specific qualifier does not apply to the procedure.

Replaced Code

3E0134Z was replaced in the 2024 ICD-10-PCS code set with the code(s):

  • 3E01340 - Introduction of Influenza Vaccine into Subcu, Perc Approach
  • 3E01340 - Introduction of Influenza Vaccine into Subcu, Perc Approach
  • 3E01340 - Introduction of Influenza Vaccine into Subcu, Perc Approach
  • 3E01340 - Introduction of Influenza Vaccine into Subcu, Perc Approach
  • 3E01340 - Introduction of Influenza Vaccine into Subcu, Perc Approach
  • XW013S6 - Introduce COVID19 Vacc Ds1 in Subcu, Perc, New Tech 6
  • XW013S6 - Introduce COVID19 Vacc Ds1 in Subcu, Perc, New Tech 6
  • XW013S6 - Introduce COVID19 Vacc Ds1 in Subcu, Perc, New Tech 6
  • XW013T6 - Introduce COVID19 Vacc Ds2 in Subcu, Perc, New Tech 6
  • XW013T6 - Introduce COVID19 Vacc Ds2 in Subcu, Perc, New Tech 6
  • XW013T6 - Introduce COVID19 Vacc Ds2 in Subcu, Perc, New Tech 6
  • XW013U6 - Introduce COVID19 Vacc in Subcu, Perc, New Tech 6
  • XW013U6 - Introduce COVID19 Vacc in Subcu, Perc, New Tech 6
  • XW013U6 - Introduce COVID19 Vacc in Subcu, Perc, New Tech 6

Clinical Classification

Convert to ICD-9-PCS

The following crosswalk between ICD-10-PCS to ICD-9-PCS is based based on the General Equivalence Mappings (GEMS) information:

Other ICD-10-PCS Codes Used for Introduction Subcutaneous Tissue

  • 3E0102A Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach
  • 3E01305 Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
  • 3E0130M Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
  • 3E01328 Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
  • 3E01329 Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach
  • 3E0132A Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
  • 3E0133Z Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach
  • 3E01340 Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach
  • 3E0136Z Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E0137Z Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E013BZ Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach
  • 3E013GC Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E013HZ Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E013KZ Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E013NZ Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
  • 3E013TZ Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
  • 3E013VG Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach
  • 3E013VJ Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach

What is ICD-10-PCS?

The ICD-10 Procedure Coding System (ICD-10-PCS) is a catalog of procedural codes used by medical professionals for hospital inpatient healthcare settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates. The 2024 ICD-10-PCS codes are to be used for discharges occurring from October 1, 2023 through September 30, 2024.

Each ICD-10-PCS code has a structure of seven alphanumeric characters and contains no decimals. The first character defines the major "section". Depending on the "section" the second through seventh characters mean different things.